Quantum BioPharma Ltd. Ordinary Shares - Class B (Sub Voting) QNTM 深 沪
等待开盘 08-06 09:30:00 美东时间
24.57
-3.230
-11.62%
华盛通- 最 高27.44
- 今 开26.87
- 成交量 24.38万股
- 最 低 24.20
- 昨 收 27.80
- 总市值 8409.57万
- 52周最高 38.25
- 市盈率 静 --
- 换手率 7.12%
- 52周最低 2.70
- 委 比 -75.51%
- 总股本 342.27万
- 历史最高 909.5234
- 量 比 1.70
- 振 幅 11.65%
- 历史最低 2.89
- 每 手 1
- 风险率 6.46%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS)
Quantum BioPharma Ltd. announced that its Phase 1 trial of Lucid-MS, a novel neuroprotective compound for multiple sclerosis, showed no safety concerns in healthy participants. The company plans to advance clinical development and initiate efficacy trials in MS patients. Lucid-MS is a first-in-class, non-immunomodulatory compound designed to prevent myelin degradation, a hallmark of MS. The successful trial supports Quantum BioPharma's progress t...
08-05 11:34
Quantum BioPharma Pursues Legal Action Over Alleged Stock Manipulation
Quantum Biopharma ( ($TSE:QNTM) ) has provided an update. On August 4, 2025, Qu...
08-04 19:57
Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing
Quantum BioPharma Ltd. has filed a legal memorandum opposing a motion by CIBC and RBC to dismiss its amended complaint alleging market manipulation between January 1, 2020, and August 15, 2024. The lawsuit claims the banks used "spoofing" techniques to depress the company's stock price, seeking over $700 million in damages. Quantum has posted relevant legal documents on its website and retains no financial burden for the case, handled on a contin...
08-04 11:33
Quantum BioPharma’s Unbuzzd Wellness Launches $5M Capital Raise
The latest announcement is out from Quantum Biopharma ( ($TSE:QNTM) ). On July ...
07-31 19:56
Quantum BioPharma-Backed Unbuzzd Launches $5M Reg D Offering With Crypto Option, Retains 25% Stake Until $1B Valuation Ahead of Potential IPO
Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) ("Quantum BioPharma"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announced that Unbuzzd Wellness
07-31 19:26
Quantum BioPharma Makes Strategic Investment in GameStop
Quantum Biopharma ( ($TSE:QNTM) ) has provided an update. On July 22, 2025, Qua...
07-22 19:28
Quantum BioPharma Makes Strategic Investment in GameStop Corp.
Quantum BioPharma Ltd. announced the purchase of 2,000 shares of GameStop Corp. as a strategic investment, aligning with its commitment to combat market corruption and enhance shareholder value. The company has been actively fighting market manipulation, including legal actions against several financial institutions alleges stock price manipulation. Additionally, the company is advancing its Multiple Sclerosis treatment, Lucid-MS, and plans to de...
07-22 11:00
Quantum BioPharma Submits Breakthrough MS Drug Candidate To UK's ILAP Program To Accelerate Patient Access
Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today
07-08 20:07
Quantum BioPharma Submits its Candidate Breakthrough Patented Drug for Multiple Sclerosis for Fast-Track Program in the United Kingdom
Quantum BioPharma Ltd. has submitted its patented drug candidate, Lucid-21-302 (Lucid-MS), to the UK's ILAP Passport program for approval as a new treatment for multiple sclerosis. The ILAP program aims to accelerate the development and approval of innovative treatments, ensuring faster access for patients. Dr. Andrzej Chruscinski and Dr. Lakshmi P. Kotra expressed excitement about the potential for Lucid-MS to address MS demyelination and highli...
07-08 12:00
Quantum Biopharma Announces Private Placement
Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to
06-28 04:39
